Substituted hydroxyapatites for bone repair

Journal of Materials Science: Materials in Medicine

Volumn 23, Issue 10, 2012, Pages 2335-2347

  Shepherd, Jennifer H ^a   Shepherd, David V ^a   Best, Serena M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL CHARACTERISTIC; BONE GRAFT; BONE REGENERATION; BONE REPAIR; CHEMICAL SIMILARITY; EFFECT OF SUBSTITUTION; HYDROXYL GROUPS; IN-VITRO; IN-VIVO; METALLIC IMPLANTS; MINERAL COMPONENT; OSTEOBLASTIC RESPONSE;

BIOLOGICAL MATERIALS; CALCIUM PHOSPHATE; FUNCTIONAL GROUPS; HYDROXYAPATITE; MAGNESIUM; STRONTIUM;

BONE;

CALCIUM CARBONATE; CALCIUM PHOSPHATE; CARBONIC ACID; FLUORIDE; HYDROXYAPATITE; MAGNESIUM; SILICATE; SILICON; SILVER; STRONTIUM; ZINC;

BIODEGRADATION; BONE REGENERATION; BONE REMODELING; CHEMICAL BOND; CHEMICAL STRUCTURE; CONFERENCE PAPER; HUMAN; IN VITRO STUDY; IN VIVO STUDY; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; SOLUBILITY; THERMOSTABILITY; X RAY DIFFRACTION;

BONE REMODELING; CATIONS; HYDROXYAPATITES; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84867398801     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-012-4598-2     Document Type: Conference Paper

References (179)

1. Rho J-Y, Kuhn-Spearing L, Zioupos P. Mechanical properties and the hierarchical structure of bone. Med Eng Phys. 1998;20:92.
2. Global Industry Analysts. Bone Grafts: a US Market Report. 2011. Accession 20 November 2011.
3. Registry NJ. NJR Stats online. 2010. Accession 20 November 2011.
4. Zhou H, Lee J. Nanoscale hydroxyapatite particles for bone tissue engineering. Acta Biomater. 2011;7:2769.
5. Sergey VD. Amorphous calcium (ortho) phosphates. Acta Biomater. 2010;6:4457-75.
6. Cai YR, Tang RK. Calcium phosphate nanoparticles in biomineralization and biomaterials. J Mater Chem. 2008;18:3775.
7. Combes C, Rey C. Amorphous calcium phosphates: synthesis, properties and uses in biomaterials. Acta Biomater. 2010;6:3362.
8. Dorozhkin SV. Bioceramics of calcium orthophosphates. Biomaterials. 2010;31:1465.
9. Sergey VD. Nanosized and nanocrystalline calcium orthophosphates. Acta Biomater. 2010;6:715-34.
10. Grant AA, Duff EJ. Apatite ceramics for use in implantation. In: Hastings GW, Williams DF, editors. Mechanical properties of biomaterials. New York: Wiley; 1980.
11. Posner AS, Perloff A, Diorio AF. Refinement of the hydroxyapatite structure. Acta Crystallogr A. 1958;11:308.
12. Kay MI, Young RA, Posner AS. Crystal structure of hydroxyapatite. Nature. 1964;204:1050.
13. Cheang P, Khor KA. Addressing processing problems associated with plasma spraying of hydroxyapatite coatings. Biomaterials. 1996;17:537.
14. Guo L, Huang M, Zhang X. Effects of sintering temperature on structure of hydroxyapatite studied with Rietveld method. J Mater Sci Mater Med. 2003;14:817.
15. Rapacz-Kmita A, Paluszkiewicz C, Ślósarczyk A, Paszkiewicz Z. FTIR and XRD investigations on the thermal stability of hydroxyapatite during hot pressing and pressureless sintering processes. J Mol Struct. 2005;744-747:653.
16. Newesely H, Osborn JF. Structural and textural implication of calcium phosphate in ceramics. In: Hasting GW, Williams DF, editors. Mechanical properties of biomaterials. New York: Wiley;1978.
17. Prakash KH, Kumar R, Ooi CP, Cheang P, Khor KA. Apparent Solubility of hydroxyapatite in aqueous medium and its influence on the morphology of nanocrystallites with precipitation temperature. Langmuir. 2006;22:11002.
18. Royer A, Viguie JC, Heughebaert M, Heughebaert JC. Stoichiometry of hydroxyapatite: influence on the flexural strength. J Mater Sci Mater Med. 1993;4:76.
19. Tagai H, Aoki H. Preparation of synthetic hydroxyapatite and sintering of apatite ceramics. In: Hastings GW, Williams DF, editors. Mechanical properties of biomaterials. New York: Wiley; 1978.
20. Best S, Bonfield W. Processing behaviour of hydroxyapatite powders with contrasting morphology. J Mater Sci Mater Med. 1994;5:516.
21. Mostafa NY. Characterization, thermal stability and sintering of hydroxyapatite powders prepared by different routes. Mater Chem Phys. 2005;94:333.
22. Albee FH, Morrison HF. Studies in bone growth: triple calcium phosphate as a stimulus to osteogenesis. Ann Surg. 1920;71:32.
23. Key JA. The effect of a local calcium depot on osteogenesis and healing of fractures. J Bone Joint Surg. 1934;16:176.
24. Murray CR. Delayed and non-union in fractures in the adult. Ann Surg. 1931;93:961.
25. Ray RD, Degge J, Gloyd P, Mooney G. Bone regeneration: an experimental study of bone-grafting. J Bone Joint Surg. 1952;34:638.
26. Bagambisa FB, Joos U. Preliminary studies on the phenomenological behaviour of osteoblasts cultured on hydroxyapatite ceramics. Biomaterials. 1990;11:50.
27. Best S, Sim B, Kayser M, Downes S. The dependence of osteoblastic response on variations in the chemical composition and physical properties of hydroxyapatite. J Mater Sci Mater Med. 1997;8:97.
28. Kim HM. Ceramic bioactivity and related biomimetic strategy. Curr Opin Solid State Mater Sci. 2003;7:289.
29. Redey SA, Razzouk S, Rey C, Bernache-Assollant D, Leroy G, Nardin M, Cournot G. Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and natural calcium carbonate: relationship to surface energies. J Biomed Mater Res. 1999;45:140.
30. Gomi K, Lowenberg B, Shapiro G, Davies JE. Resorption of sintered synthetic hydroxyapatite by osteoclasts in vitro. Biomaterials. 1993;14:91.
31. Monchau F, Lefèvre A, Descamps M, Belquin-myrdycz A, Laffargue P, Hildebrand HF. In vitro studies of human and rat osteoclast activity on hydroxyapatite, b-tricalcium phosphate, calcium carbonate. Biomol Eng. 2002;19:143.
32. Webster TJ, Ergun C, Doremus RH, Siegel RW, Bizios R. Enhanced osteoclast-like cell functions on nanophase ceramics. Biomaterials. 2001;22:1327.
33. Yuan H, Kurashina K, de Bruijn JD, Li Y, de Groot K, Zhang X. A preliminary study on osteoinduction of two kinds of calcium phosphate ceramics. Biomaterials. 1999;20:1799.
34. Annaz B, Hing KA, Kayser M, Buckland T, Silvio LD. Porosity variation in hydroxyapatite and osteoblast morphology: a scanning electron microscopy study. J Microsc. 2004;215:100.
35. Frame JW, Browne RM, Brady CL. Hydroxyapatite as a bone substitute in the jaws. Biomaterials. 1981;2:19.
36. Sepulveda P, Bressiani AH, Bressiani JC, Meseguer L, König B Jr. In vivo evaluation of hydroxyapatite foams. J Biomed Mater Res. 2002;62:587.
37. Mastrogiacomo M, Scaglione S, Martinetti R, Dolcini L, Beltrame F, Cancedda R, Quarto R. Role of scaffold internal structure on in vivo bone formation in macroporous calcium phosphate bioceramics. Biomaterials. 2006;27:3230.
38. McCord JF. An investigation into the effects of dense hydroxyapatite on bone strength. Dent Mater. 1988;4:68.
39. LeGeros RZ. Biological and synthetic apatites. In: Brown PW, Constantz B, editors. Hydroxyapatite and related compounds. San Francisco: CRC press; 1993. p. 3.
40. Legeros RZ. Calcium Phosphates in Oral Biology and Medicine. In: Myers H, editors. Monographs in Oral Science. Basel: Karger; 1991. Vol 15. p. IX-201.
41. Rude RK, Gruber HE. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 2004;15:710.
42. Percival M. Bone Health and Osteoporosis. Appl nutr sci rep. 1999;5:1.
43. Bigi A, Foresti E, Gregorini R, Ripamonti A, Roveri N, Shah JS. The role of magnesium on the structure of biological apatites. Calcif Tissue Int. 1992;50:439.
44. Bertoni E, Bigi A, Cojazzi G, Gandolfi M, Panzavolta S, Roveri N. Nanocrystals of magnesium and fluoride substituted hydroxyapatite. J Inorg Biochem. 1998;72:29.
45. Bigi A, Falini G, Foresti E, Gazzano M, Ripamonti A, Roveri N. Magnesium influence on hydroxyapatite crystallization. J Inorg Biochem. 1993;49:69.
46. Landi E, Logroscino G, Proietti L, Tampieri A, Sandri M, Sprio S. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J Mater Sci Mater Med. 2008;19:239.
47. Ren F, Leng Y, Xin R, Ge X. Synthesis, characterization and ab initio simulation of magnesium-substituted hydroxyapatite. Acta Biomater. 2010;6:2787.
48. Cacciotti I, Bianco A, Lombardi M, Montanaro L. Mg-substituted hydroxyapatite nanopowders: synthesis, thermal stability and sintering behaviour. J Eur Ceram Soc. 2009;29:2969.
49. Suchanek WL, Byrappa K, Shuk P, Riman RE, Janas VF, Ten-Huisen KS. Preparation of magnesium-substituted hydroxyapatite powders by the mechanochemical-hydrothermal method. Biomaterials. 2004;25:4647.
50. Laurencin D, Almora-Barrios N, de Leeuw NH, Gervais C, Bonhomme C, Mauri F, Chrzanowski W, Knowles JC, Newport RJ, Wong A, Gan Z, Smith ME. Magnesium incorporation into hydroxyapatite. Biomaterials. 2011;32:1826.
51. Serre CM, Papillard M, Chavassieux P, Voegel JC, Boivin G. Influence of magnesium substitution on a collagen-apatite biomaterial on the production of a calcifying matrix by human osteoblasts. J Biomed Mater Res. 1998;42:626.
52. Caneva M, Botticelli D, Stellini E, Souza SLS, Salata LA, Lang NP. Magnesium-enriched hydroxyapatite at immediate implants: a histomorphometric study in dogs. Clin Oral Implant Res. 2011;22:512.
53. de Lima IR, Alves GG, Soriano CA, Campaneli AP, Gasparoto TH, Ramos ES, de Sena LA, Rossi AM, Granjeiro JM. Understanding the impact of divalent cation substitution on hydroxyapatite: an in vitro multiparametric study on biocompatibility. J Biomed Mater Res, Part A. 2011;98 A: 351.
54. Hamilton-Miller JMT, Shah S. A microbiological assessment of silver fusidate, a novel topical antimicrobial agent. Int J Antimicrob Agents. 1996;7:97.
55. Adams AP, Santschi EM, Mellencamp MA. Antibacterial properties of a silver chloride-coated nylon wound dressing. Vet Surg. 1999;28:219.
56. Matsuura T, Abe Y, Sato Y, Okamoto K, Ueshige M, Akagawa Y. Prolonged antimicrobial effect of tissue conditioners containing silver-zeolite. J Dent. 1997;25:373.
57. George N, Faoagali J, Muller M. Silvazine (TM) (silver sulfadiazine and chlorhexidine) activity against 200 clinical isolates. Burns. 1997;23:493.
58. Kim TN, Feng QL, Kim JO, Wu J, Wang H, Chen GQ, Cui FZ. Antimicrobial effects of metal ions (Ag (+), Cu (2+), Zn (2+)) in hydroxyapatite. J Mater Sci Mater Med. 1998;9:129.
59. Rameshbabu N, Kumar TSS, Prabhakar TG, Sastry VS, Murty K, Rao KP. Antibacterial nanosized silver substituted hydroxyapatite: synthesis and characterization. J Biomed Mater Res, Part A. 2007;80 A: 581.
60. Chen Y, Zheng X, Xie Y, Ji H, Ding C, Li H, Dai K. Silver release from silver-containing hydroxyapatite coatings. Surf Coat Technol. 2010;205:1892.
61. Chen W, Oh S, Ong AP, Oh N, Liu Y, Courtney HS, Appleford M, Ong JL. Antibacterial and osteogenic properties hydroxyapatite coatings produced using of silver-containing a sol gel process. J Biomed Mater Res, Part A. 2007;82 A: 899.
62. Stanic V, Janackovic D, Dimitrijevic S, Tanaskovic SB, Mitric M, Pavlovic MS, Krstic A, Jovanovic D, Raicevic S. Synthesis of antimicrobial monophase silver-doped hydroxyapatite nanopowders for bone tissue engineering. Appl Surf Sci. 2011;257:4510.
63. Badrour L, Sadel A, Zahir M, Kimakh L, El Hajbi A. Synthesis and physical and chemical characterization of Ca10-xAgx (PO4) (6) (OH) (2-x) square (x) apatites. Ann Chim Sci Mat. 1998;23:61.
64. Chen YM, Miao XG. Thermal and chemical stability of fluorohydroxyapatite ceramics with different fluorine contents. Biomaterials. 2005;26:1205.
65. Naddari T, Hamdi B, Savariault JM, El Feki H, Ben Salah A. Substitution mechanism of alkali metals for strontium in strontium hydroxyapatite. Mater Res Bull. 2003;38:221.
66. Blake GM, Zivanovic MA, McEwan AJ, Ackery DM. SR-89 Therapy - Strontium kinetics in disseminated carcinoma of the prostate. Eur J Nucl Med. 1986;12:447.
67. Marie PJ, Ammann P, Boivin G, Rey C. Mechanisms of action and therapeutic potential of strontium in bone. Calcif Tissue Int. 2001;69:121.
68. Caverzasio J. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone. 2008;42:1131.
69. Reginster JY. Strontium ranelate in osteoporosis. Curr Pharm Design. 2002;8:1907.
70. Peng SL, Zhou GQ, Luk KDK, Cheung KMC, Li ZY, Lam WM, Zhou ZJ, Lu WW. Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem. 2009;23:165.
71. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, Terwilliger EF, Brown EM, Brazier M. The calcium-sensing receptor is involved in strontium ranelateinduced osteoclast apoptosis: new insights into the associated signaling pathways. J Biol Chem. 2009;284:575.
72. Buehler J, Chappuis P, Saffar JL, Tsouderos Y, Vignery A. Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis). Bone. 2001;29:176.
73. Guida A, Towler MR, Wall JG, Hill RG, Eramo S. Preliminary work on the antibacterial effect of strontium in glass ionomer cements. J Mater Sci Lett. 2003;22:1401.
74. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY, Graham J, Ng KW, Prince R, Prins J, Wark J, Devogelaer JP, Kaufman JM, Raeman F, Ziekenhuis JP, Walravens M, Beck-Nielsen H, Charles P, Sorensen OH, Aquino JP, Benhamou C, Blotman F, Bonidan O, Bourgeois P, Dehais J, Fardellone P, Kahan A, Kuntz JL, Marcelli C, Prost A, Vellas B, Weryha G, Felsenberg D, Hensen J, Kruse HP, Schmidt W, Semler J, Stucki G, Phenekos C, De Chatel R, Adami S, Bianchi G, Brandi ML, Cucinotta D, Fiore C, Gennari C, Isaia G, Luisetto G, Passariello R, Passeri M, Rovetta G, Tessari L, Hoszowski K, Lorenc RS, Sawicki A, Diez A, Cannata JB, Curiel MD, Rapado A, Gijon J, Torrijos A, Padrino JM, Varela AR, Bonjour JP, Clements M, Doyle DV, Ryan P, Smith IG, Smith R. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med. 2004;350:459.
75. Bigi A, Boanini E, Capuccini C, Gazzano M. Strontiumsubstituted hydroxyapatite nanocrystals. Inorg Chim Acta. 2007;360:1009.
76. O'Donnell MD, Fredholm Y, de Rouffignac A, Hill RG. Structural analysis of a series of strontium-substituted apatites. Acta Biomater. 2008;4:1455.
77. Christoffersen J, Christoffersen MR, Kolthoff N, Barenholdt O. Effects of strontium ions on growth and dissolution of hydroxyapatite and on bone mineral detection. Bone. 1997;20:47.
78. Boanini E, Torricelli P, Fini M, Bigi A. Osteopenic bone cell response to strontium-substituted hydroxyapatite. J Mater Sci Mater Med. 2011;22:2079.
79. Zhu K, Yanagisawa K, Shimanouchi R, Onda A, Kajiyoshi K. Preferential occupancy of metal ions in the hydroxyapatite solid solutions synthesized by hydrothermal method. J Eur Ceram Soc. 2006;26:509.
80. Bigi A, Falini G, Gazzano M, Roveri N, Tedesco E. Structural refinements of strontium substituted hydroxylapatites. Mater Sci Forum. 1998;278(2):814.
81. Pan HB, Li ZY, Lam WM, Wong JC, Darvell BW, Luk KDK, Lu WW. Solubility of strontium-substituted apatite by solid titration. Acta Biomater. 2009;5:1678.
82. Zhang W, Shen Y, Pan H, Lin K, Liu X, Darvell BW, Lu WW, Chang J, Deng L, Wang D, Huang W. Effects of strontium in modified biomaterials. Acta Biomater. 2011;7:800.
83. Verberckmoes SC, Behets GJ, Oste L, Bervoets AR, Lamberts LV, Drakopoulos M, Somogyi A, Cool P, Dorrine W, De Broe ME, D'Haese PC. Effects of strontium on the physicochemical characteristics of hydroxyrapatite. Calcif Tissue Int. 2004;75:405.
84. Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscino G. Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater. 2007;3:961.
85. Ni GX, Chiu KY, Lu WW, Wang Y, Zhang YG, Hao LB, Li ZY, Lam WM, Lu SB, Luk KDK. Strontium-containing hydroxyapatite bioactive bone cement in revision hip arthroplasty. Biomaterials. 2006;27:4348.
86. Ni GX, Yao ZP, Huang GT, Liu WG, Lu WW. The effect of strontium incorporation in hydroxyapatite on osteoblasts in vitro. J Mater Sci Mater Med. 2011;22:961.
87. Capuccini C, Torricelli P, Sima F, Boanini E, Ristoscu C, Bracci B, Socol G, Fini M, Mihailescu IN, Bigi A. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. Acta Biomater. 2008;4:1885.
88. Kishi S, Yamaguchi M. Inhibitory effect of zinc-compounds on osteoclast-like cell-formation in mouse marrow cultures. Biochem Pharmacol. 1994;48:1225.
89. Moonga BS, Dempster DW. Zinc is a potent inhibitor of osteoclastic bone-resorption in vitro. J Bone Miner Res. 1995;10:453.
90. Yamaguchi M, Uchiyama S. Receptor activator of NF-kB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med. 2004;14:81.
91. Yamaguchi M, Goto M, Uchiyama S, Nakagawa T. Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. Mol Cell Biochem. 2008;312:157.
92. Khadeer MA, Sahu SN, Bai G, Abdulla S, Gupta A. Expression of the zinc transporter ZIP1 in osteoclasts. Bone. 2005;37:296.
93. Yamaguchi M, Yamaguchi R. Action of zinc on bone metabolism in rats - increases in alkaline-phosphatase activity and DNA content. Biochem Pharmacol. 1986;35:773.
94. Yamaguchi M, Oishi H, Suketa Y. Stimulatory effect of zinc on bone-formation in tissue-culture. Biochem Pharmacol. 1987;36:4007.
95. Ergun C, Webster TJ, Bizios R, Doremus RH. Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. I. Structure and microstructure. J Biomed Mater Res. 2002;59:305.
96. Webster TJ, Massa-Schlueter EA, Smith JL, Slamovich EB. Osteoblast response to hydroxyapatite doped with divalent and trivalent cations. Biomaterials. 2004;25:2111.
97. Sogo Y, Ito A, Fukasawa K, Sakurai T, Ichinose N. Zinc containing hydroxyapatite ceramics to promote osteoblastic cell activity. Mater Sci Technol. 2004;20:1079.
98. Miyaji F, Kono Y, Suyama Y. Formation and structure of zincsubstituted calcium hydroxyapatite. Mater Res Bull. 2005;40:209.
99. Grandjean-Laquerrier A, Laquerriere P, Jallot E, Nedelec JM, Guenounou M, Laurent-Maquin D, Phillips TM. Influence of the zinc concentration of sol-gel derived zinc substituted hydroxyapatite on cytokine production by human monocytes in vitro. Biomaterials. 2006;27:3195.
100. Chung RJ, Hsieh MF, Huang CW, Perng LH, Wen HW, Chin TS. Antimicrobial effects and human gingival biocompatibility of hydroxyapatite sol-gel coatings. J Biomed Mater Res, Part B. 2006;76 B: 169.
101. Velard F, Laurent-Maquin D, Braux J, Guillaume C, Bouthors S, Jallot E, Nedelec JM, Belaaouaj A, Laquerriere P. The effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammation. Biomaterials. 2010;31:2001.
102. Ma X, Ellis DE. Initial stages of hydration and Zn substitution/ occupation on hydroxyapatite (0001) surfaces. Biomaterials. 2008;29:257.
103. Matos M, Terra J, Ellis DE. Mechanism of Zn stabilization in hydroxyapatite and hydrated (001) surfaces of hydroxyapatite. J Phys: Condes Matter. 2010;22:7.
104. Terra J, Jiang M, Ellis DE. Characterization of electronic structure and bonding in hydroxyapatite: Zn substitution for Ca. Philos Mag A-Phys Condens Matter Struct Defect Mech Prop. 2002;82:2357.
105. Tang YZ, Chappell HF, Dove MT, Reeder RJ, Lee YJ. Zinc incorporation into hydroxylapatite. Biomaterials. 2009;30:2864.
106. Matsunaga K. First-principles study of substitutional magnesium and zinc in hydroxyapatite and octacalcium phosphate. J Chem Phys. 2008;128:245101.
107. Yin X, Calderin L, Stott MJ, Sayer M. Density functional study of structural, electronic and vibrational properties of Mg-and Zn-doped tricalcium phosphate biomaterials. Biomaterials. 2002;23:4155.
108. Ren FZ, Xin RL, Ge X, Leng Y. Characterization and structural analysis of zinc-substituted hydroxyapatites. Acta Biomater. 2009;5:3141.
109. Li MO, Xiao XF, Liu RF, Chen CY, Huang LZ. Structural characterization of zinc-substituted hydroxyapatite prepared by hydrothermal method. J Mater Sci Mater Med. 2008;19:797.
110. Ito A, Ojima K, Naito H, Ichinose N, Tateishi T. Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res. 2000;50:178.
111. 2+ in zinc-containing beta-tricalcium phosphate on resorbing activity of mature osteoclasts. J Biomed Mater Res, Part A. 2008;84 A: 344.
112. Kawamura H, Ito A, Miyakawa S, Layrolle P, Ojima K, Ichinose N, Tateishi T. Stimulatory effect of zinc-releasing calcium phosphate implant on bone formation in rabbit femora. J Biomed Mater Res. 2000;50:184.
113. Stanic V, Dimitrijevic S, Antic-Stankovic J, Mitric M, Jokic B, Plecas IB, Raicevic S. Synthesis, characterization and antimicrobial activity of copper and zinc-doped hydroxyapatite nanopowders. Appl Surf Sci. 2010;256:6083.
114. Montel G, Bonel G, Heughebaert JC, Trombe JC, Rey C. New concepts in the composition, crystallization and growth of the mineral component of calcified tissues. J Cryst Growth. 1981;53:74.
115. Bigi A, Cojazzi G, Panzavolta S, Ripamonti A, Roveri N, Romanello M, Suarez KN, Moro L. Chemical and structural characterization of the mineral phase from cortical and trabecular bone. J Inorg Biochem. 1997;68:45.
116. Landi E, Celotti G, Logroscino G, Tampieri A. Carbonated hydroxyapatite as bone substitute. J Eur Ceram Soc. 2003;23:2931.
117. Legeros RZ. Apatites in biological systems. Prog Cryst Growth Charact Mater. 1981;4:1.
118. Chiranjeevirao SV, Voegel JC, Frank RM. A method of preparation and characterization of carbonato-apatites. Inorg Chim Acta. 1983;78:43.
119. Barralet J, Best S, Bonfield W. Carbonate substitution in precipitated hydroxyapatite: an investigation into the effects of reaction temperature and bicarbonate ion concentration. J Biomed Mater Res. 1998;41:79.
120. Liao S, Watari F, Xu G, Ngiam M, Ramakrishna S, Chan CK. Morphological effects of variant carbonates in biomimetic hydroxyapatite. Mater Lett. 2007;61:3624.
121. Barralet J, Knowles JC, Best S, Bonfield W. Thermal decomposition of synthesised carbonate hydroxyapatite. J Mater Sci Mater Med. 2002;13:529.
122. Merry JC, Gibson IR, Best SM, Bonfield W. Synthesis and characterization of carbonate hydroxyapatite. J Mater Sci Mater Med. 1998;9:779.
123. Ito A, Maekawa K, Tsutsumi S, Ikazaki F, Tateishi T. Solubility product of OH-carbonated hydroxyapatite. J Biomed Mater Res. 1997;36:522.
124. Nordström EG, Karlsson KH. Carbonate-doped hydroxyapatite. J Mater Sci Mater Med. 1990;1:182.
125. Vignoles M, Bonel G, Holcomb D, Young R. Influence of preparation conditions on the composition of type B carbonated hydroxyapatite and on the localization of the carbonate ions. Calcif Tissue Int. 1988;43:33.
126. Doi Y, Shibutani T, Moriwaki Y, Kajimoto T, Iwayama Y. Sintered carbonate apatites as bioresorbable bone substitutes. J Biomed Mater Res. 1998;39:603.
127. Driessens FCM, Verbeeck RMH, Heijligers HJM. Some physical properties of Na-and CO3-containing apatites synthesized at high temperatures. Inorg Chim Acta. 1983;80:19.
128. Gibson IR, Bonfield W. Novel synthesis and characterization of an AB-type carbonate-substituted hydroxyapatite. J Biomed Mater Res. 2002;59:697.
129. Murugan R, Ramakrishna S. Production of ultra-fine bioresorbable carbonated hydroxyapatite. Acta Biomater. 2006;2:201.
130. Porter A, Patel N, Brooks R, Best S, Rushton N, Bonfield W. Effect of carbonate substitution on the ultrastructural characteristics of hydroxyapatite implants. J Mater Sci Mater Med. 2005;16:899.
131. LeGeros RZ, Trautz OR, LeGeros RZ, Klein L, Shirra WP. Apatite crystallites: effect of carbonate on morphology. Science. 1967;155:1409.
132. Spence G, Patel N, Brooks R, Rushton N. Carbonate substituted hydroxyapatite: resorption by osteoclasts modifies the osteoblastic response. J Biomed Mater Res, Part A. 2009;90 A: 217.
133. Mertz W. The essential trace-elements. Science. 1981;213:1332.
134. Moller PF, Gudjonsson SV. Massive fluorosis of bones and ligaments. Acta Radiol. 1932;13:269.
135. Roholm K. Fluorine intoxication: a clinical-hygienic study. London: H. K. Lewis; 1937.
136. Rich C, Ivanovics P, Ensinck J. Effects of sodium fluoride on calcium metabolism of subjects with metabolic bone diseases. J Clin Invest. 1964;43:545.
137. Cass RM, Croft JD, Perkins P, Nye W, Waterhou C, Terry R. New bone formation in osteoporosis following treatment with sodium fluoride. Arch Intern Med. 1966;118:111.
138. Farley SMG, Wergedal JE, Smith LC, Lundy MW, Farley JR, Baylink DJ. Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkalinephosphatase activity. Metab, Clin Exp. 1987;36:211.
139. Briancon D, Meunier PJ. Treatment of osteoporosis with fluoride, calcium, and vitamin-D. Orthop Clin North Am. 1981;12:629.
140. Riggs BL, Hodgson SF, Hoffman DL, Kelly PJ, Johnson KA, Taves D. Treatment of primary osteoporosis with fluoride and calcium: clinical tolerance and fracture occurrence. J Am Med Assoc. 1980;243:446.
141. Boivin G, Chapuy MC, Baud CA, Meunier PJ. Fluoride content in human iliac bone: results in controls, patients with fluorosis, and osteoporotic patients treated with fluoride. J Bone Miner Res. 1988;3:497.
142. Guanabens N, Farrerons J, Perez-Edo L, Monegal A, Renau A, Carbonell J, Roca M, Torra M, Pavesi M. Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial. Bone. 2000;27:123.
143. Farley JR, Wergedal JE, Baylink DJ. Fluoride directly stimulates proliferation and alkaline-phosphatase activity of boneforming cells. Science. 1983;222:330.
144. Chavassieux P, Boivin G, Serre CM, Meunier PJ. Fluoride increases rat osteoblast function and population after in vivo administration but not after in vitro exposure. Bone. 1993;14:721.
145. Wei M, Evans JH, Bostrom T, Grondahl L. Synthesis and characterization of hydroxyapatite, fluoride-substituted hydroxyapatite and fluorapatite. J Mater Sci Mater Med. 2003;14:311.
146. Bianco A, Cacciotti I, Lombardi M, Montanaro L, Bemporad E, Sebastiani M. F-substituted hydroxyapatite nanopowders: thermal stability, sintering behaviour and mechanical properties. Ceram Int. 2010;36:313.
147. Jha LJ, Best SM, Knowles JC, Rehman I, Santos JD, Bonfield W. Preparation and characterization of fluoride-substituted apatites. J Mater Sci Mater Med. 1997;8:185.
148. Cavalli M, Gnappi G, Montenero A, Bersani D, Lottici PP, Kaciulis S, Mattogno G, Fini M. Hydroxy-and fluorapatite films on Ti alloy substrates: sol-gel preparation and characterization. J Mater Sci. 2001;36:3253.
149. Moreno EC, Kresak M, Zahradni RT. Fluoridated hydroxyapatite solubility and caries formation. Nature. 1974;247:64.
150. Rodriguez-Lorenzo LM, Hart JN, Gross KA. Structural and chemical analysis of well-crystallized hydroxyfluorapatites. J Phys Chem B. 2003;107:8316.
151. Kannan S, Rebelo A, Ferreira JMF. Novel synthesis and structural characterization of fluorine and chlorine co-substituted hydroxyapatites. J Inorg Biochem. 2006;100:1692.
152. Eslami H, Solati-Hashjin M, Tahriri M. The comparison of powder characteristics and physicochemical, mechanical and biological properties between nanostructure ceramics of hydroxyapatite and fluoridated hydroxyapatite. Mater Sci Eng C-Biomimetic Supramol Syst. 2009;29:1387.
153. Legeros RZ, Kijkowska R, Jia W, Legeros JP. Fluoride-cation interactions in the formation and stability of apatites. J Fluor Chem. 1988;41:53.
154. Bhadang KA, Gross KA. Influence of fluorapatite on the properties of thermally sprayed hydroxyapatite coatings. Biomaterials. 2004;25:4935.
155. Cheng K, Weng WJ, Wang HM, Zhang S. In vitro behavior of osteoblast-like cells on fluoridated hydroxyapatite coatings. Biomaterials. 2005;26:6288.
156. Rodriguez-Lorenzo LM, Hart JN, Gross KA. Influence of fluorine in the synthesis of apatites. Synthesis of solid solutions of hydroxy-fluorapatite. Biomaterials. 2003;24:3777.
157. Montanaro L, Arciola CR, Campoccia D, Cervellati M. In vitro effects on MG63 osteoblast-like cells following contact with two roughness-differing fluorohydroxyapatite-coated titanium alloys. Biomaterials. 2002;23:3651.
158. Kim H-W, Kim H-E, Knowles JC. Fluor-hydroxyapatite sol-gel coating on titanium substrate for hard tissue implants. Biomaterials. 2004;25:3351.
159. Wang YS, Zhang S, Zeng XT, Ma LL, Khor KA, Qian M. Initial attachment of osteoblastic cells onto sol-gel derived fluoridated hydroxyapatite coatings. J Biomed Mater Res, Part A. 2008;84 A: 769.
160. Ge X, Leng Y, Bao CY, Xu SL, Wang RK, Ren FZ. Antibacterial coatings of fluoridated hydroxyapatite for percutaneous implants. J Biomed Mater Res, Part A. 2010;95 A: 588.
161. Carlisle EM. Silicon: a possible factor in bone calcification. Science. 1970;167:279.
162. Carlisle EM. Silicon: an essential element for chick. Science. 1972;178:619.
163. Arumugam MQ, Ireland DC, Brooks RA, Rushton N, Bonfield W. Orthosilicic acid increases collagen type I mRNA expression in human bone-derived osteoblasts in vitro. In: Barbosa MA, Monteiro FJ, Correia R, Leon B, editors. 16th International Symposium on Ceramics in Medicine. Porto: Trans Tech Publications Ltd; 2003. p. 869.
164. Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HFJ, Evans BAJ, Thompson RPH, Powell JJ, Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone. 2003;32:127.
165. Jugdaohsingh R, Calomme MR, Robinson K, Nielsen F, Anderson SHC, D'Haese P, Geusens P, Loveridge N, Thompson RPH, Powell JJ. Increased longitudinal growth in rats on a silicondepleted diet. Bone. 2008;43:596.
166. Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. J Biomed Mater Res. 1999;44:422.
167. Tanizawa Y, Suzuki T. X-ray photoelectron spectroscopy study of silicate-containing apatite. Phosphorous Res Bull. 1994;4:83.
168. Sugiyama K, Suzuki T, Satoh T. Bactericidal activity of silicatecontaining apatite. J Antibact Antifung Agents. 1995;23:67.
169. Leventouri T, Bunaciu CE, Perdikatsis V. Neutron powder diffraction studies of silicon-substituted hydroxyapatite. Biomaterials. 2003;24:4205.
170. Botelho CM, Lopes MA, Gibson IR, Best SM, Santos JD. Structural analysis of Si-substituted hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy. J Mater Sci: Mater Med. 2002;13:1123.
171. Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Comparison of in vivo dissolution processes in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials. 2003;24:4609.
172. Porter AE, Botelho CM, Lopes MA, Santos JD, Best SM, Bonfield W. Ultrastructural comparison of dissolution and apatite precipitation on hydroxyapatite and silicon-substituted hydroxyapatite in vitro and in vivo. J Biomed Mater Res, Part A. 2004;69 A: 670.
173. Tang Q, Brooks R, Rushton N, Best S. Production and characterization of HA and SiHA coatings. J Mater Sci: Mater Med. 2010;21:173.
174. San Thian E, Ahmad Z, Huang J, Edirisinghe MJ, Jayasinghe SN, Ireland DC, Brooks RA, Rushton N, Bonfield W, Best SM. The role of electrosprayed apatite nanocrystals in guiding osteoblast behaviour. Biomaterials. 2008;29:1833.
175. Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials. 2006;27:5014.
176. Landi E, Uggeri J, Sprio S, Tampieri A, Guizzardi S. Human osteoblast behavior on as-synthesized SiO (4) and B-CO (3) co-substituted apatite. J Biomed Mater Res, Part A. 2010;94 A: 59.
177. Sprio S, Tampieri A, Landi E, Sandri M, Martorana S, Celotti G, Logroscino G. Physico-chemical properties and solubility behaviour of multi-substituted hydroxyapatite powders containing silicon. Mater Sci Eng C-Biomimetic Supramol Syst. 2008;28:179.
178. Landi E, Sprio S, Sandri M, Celotti G, Tampieri A. Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications. Acta Biomater. 2008;4:656.
179. Stephen JA, Skakle JMS, Gibson IR. Synthesis of novel high silicate-substituted hydroxyapatite by co-substitution mechanisms. Bioceramics. 2007; vol 19, Pts 1 and 2, vol. 330-332. p. 87.